Conformational changes of P-glycoprotein by nucleotide binding.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Biochemical Journal

• Publication date

  1997-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ3280897PMID 9396736PMCID PMC1219002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein.

  1997cited by this paper
• MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.

  1996cited by this paper
• Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.

  1996cited by this paper
• Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug-transport mechanism.

  1996cited by this paper
• P-glycoproteins and multidrug resistance.

  1996cited by this paper
• Characterization and epitope mapping of several new anti‐P‐glycoprotein monoclonal antibodies

  1996cited by this paper
• Secondary and Tertiary Structure Changes of Reconstituted P-glycoprotein

  1996cited by this paper
• Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.

  1995cited by this paper
• Multidrug Resistance Protein (Mdr)-alkaline Phosphatase Hybrids in Escherichia coli Suggest a Major Revision in the Topology of the C-terminal Half of Mdr (*)

  1995cited by this paper
• Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells.

  1995cited by this paper
• P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site (*)

  1995cited by this paper
• The catalytic cycle of P‐glycoprotein

  1995cited by this paper
• Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*)

  1995cited by this paper
• Characterization and functional reconstitution of the multidrug transporter

  1995cited by this paper
• The MDR superfamily of genes and its biological implications.

  1994cited by this paper
• Nucleotide-induced conformational changes of MalK, a bacterial ATP binding cassette transporter protein.

  1994cited by this paper
• Membrane topology of multidrug resistance protein expressed in Escherichia coli. N-terminal domain.

  1994cited by this paper
• ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells.

  1994cited by this paper
• Covalent inhibitors of P-glycoprotein ATPase activity.

  1994cited by this paper
• Identification of a translocated protein segment in a voltage-dependent channel

  1994cited by this paper
• Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals.

  1993cited by this paper
• Evidence for an alternate model of human P-glycoprotein structure and biogenesis.

  1993cited by this paper
• ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance.

  1993cited by this paper
• Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein.

  1993cited by this paper
• Effects of competitive sodium-like antagonists on Na,K-ATPase suggest that cation occlusion from the cytoplasmic surface occurs in two steps.

  1993cited by this paper
• Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule.

  1993cited by this paper
• Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

  1993cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.

  1992cited by this paper
• Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.

  1992cited by this paper
• ABC transporters: from microorganisms to man.

  1992cited by this paper
• Modulation of ATP and drug binding by monoclonal antibodies against P‐glycoprotein

  1991cited by this paper
• Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation.

  1991cited by this paper
• Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport

  1990cited by this paper
• Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.

  1990cited by this paper
• Characterization of the catalytic subunit of an anion pump.

  1989cited by this paper
• Pyridoxal 5'-diphospho-5'-adenosine binds at a single site on isolated alpha-subunit from Escherichia coli F1-ATPase and specifically reacts with lysine 201.

  1988cited by this paper
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

  1986cited by this paper
• Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

  1986cited by this paper
• Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.

  1986cited by this paper
• Conformational change of the alpha subunit of Escherichia coli F1 ATPase: ATP changes the trypsin sensitivity of the subunit.

  1983cited by this paper
• Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability.

  1979cited by this paper
• Purification and characterization of (Na+, K+)-ATPase. V. Conformational changes in the enzyme Transitions between the Na-form and the K-form studied with tryptic digestion as a tool.

  1975cited by this paper
• Proteins of the human erythrocyte membrane as modified by pronase.

  1971cited by this paper

• The Role of P-Glycoprotein (P-gp) in Cancer Multidrug Resistance (MDR): Challenges for Inhibiting P-gp in the Context of Overcoming MDR

  2023cites this paper
• Cross-linking, DEER-spectroscopy and molecular dynamics confirm the inward facing state of P-glycoprotein in a lipid membrane.

  2020cites this paper
• The conformation and dynamics of P‐glycoprotein in a lipid bilayer investigated by atomic force microscopy

  2018cites this paper
• Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein

  2018cites this paper
• Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer–associated P-glycoprotein during ATP hydrolysis

  2017cites this paper
• Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during hydrolysis

  2017cites this paper
• Establishment of P‐Glycoprotein Structure–Transport Relationships to Optimize CNS Exposure in Drug Discovery

  2015cites this paper
• Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer

  2012cites this paper
• 8.8 Molecular Aspects of the Translocation Process by ABC Proteins

  2012cites this paper
• The emerging role of nuclear factor kappa B in renal cell carcinoma.

  2011cites this paper
• The ABC Transporters: Structural Insights into Drug Transport

  2009cites this paper
• Functional role of the linker region in purified human P‐glycoprotein

  2009cites this paper
• ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters

  2008cites this paper
• Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.

  2007cites this paper
• Allosteric modulation of the human P-glycoprotein involves conformational changes mimicking catalytic transition intermediates.

  2006cites this paper
• Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.

  2006cites this paper
• Role of Mechanistic Transport Studies in Lead Optimization

  2006cites this paper
• Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.

  2006cites this paper
• Allosteric Modulation Bypasses the Requirement for ATP Hydrolysis in Regenerating Low Affinity Transition State Conformation of Human P-glycoprotein*

  2006cites this paper
• Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1)*

  2006cites this paper
• ATP Induces Conformational Changes of Periplasmic Loop Regions of the Maltose ATP-binding Cassette Transporter*

  2006cites this paper
• The translocation mechanism of P‐glycoprotein

  2006cites this paper
• GSH Inhibits Trypsinization of the C-terminal Half of Human MRP1*

  2005cites this paper
• Three-dimensional Structure of P-glycoprotein

  2005cites this paper
• The Q-loop Disengages from the First Intracellular Loop during the Catalytic Cycle of the Multidrug ABC Transporter BmrA*

  2005cites this paper
• Maltose-binding Protein Is Open in the Catalytic Transition State for ATP Hydrolysis during Maltose Transport*

  2004cites this paper
• Molecular Pathways of Drug Resistance

  2004cites this paper
• Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

  2004cites this paper
• Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.

  2003cites this paper
• Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding*

  2003cites this paper
• The nucleotide-binding domains of P-glycoprotein. Functional symmetry in the isolated domain demonstrated by N-ethylmaleimide labelling.

  2003cites this paper
• Intermediate Structural States Involved in MRP1-mediated Drug Transport

  2003cites this paper
• CHAPTER 6 – PROBING OF CONFORMATIONAL CHANGES, CATALYTIC CYCLE AND ABC TRANSPORTER FUNCTION

  2003cites this paper
• Proteolytic Cleavage of the Linker Region of the Human P-glycoprotein Modulates Its ATPase Function*

  2002cites this paper
• Structural and Functional Consequences of Mutating Cysteine Residues in the Amino Terminus of Human Multidrug Resistance-associated Protein 1*

  2002cites this paper
• Structural and Functional Asymmetry of the Nucleotide-binding Domains of P-glycoprotein Investigated by Attenuated Total Reflection Fourier Transform Infrared Spectroscopy*

  2002cites this paper
• Contribution of efflux pump activity to the delivery of pulmonary therapeutics.

  2002cites this paper
• Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.

  2002cites this paper
• Nucleotide-induced conformational changes of PMP70, an ATP binding cassette transporter on rat liver peroxisomal membranes.

  2002cites this paper
• Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.

  2002cites this paper
• Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.

  2001cites this paper
• P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation.

  2001cites this paper
• Further characterization of the sixth transmembrane domain of Pgp1 by site-directed mutagenesis

  2001cites this paper
• Distinct functional properties of the TAP subunits coordinate the nucleotide-dependent transport cycle.

  2001cites this paper
• Nucleotide‐induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells

  2001cites this paper
• The multi-structural feature of the multidrug resistance gene product P-glycoprotein: implications for its mechanism of action

  2001cites this paper
• From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

  2001cites this paper
• Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle

  2001cites this paper
• The effect of glutathione on the ATPase activity of MRP1 in its natural membranes

  2000cites this paper
• Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane.

  2000cites this paper
• Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.

  2000cites this paper
• The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility

  2000cites this paper
• Secondary and Tertiary Structure Changes of Reconstituted LmrA Induced by Nucleotide Binding or Hydrolysis

  2000cites this paper
• Multidrug resistance protein MRP1 reconstituted into lipid vesicles: secondary structure and nucleotide-induced tertiary structure changes.

  2000cites this paper
• Regulation of CFTR Cl- channel gating by ATP binding and hydrolysis.

  2000cites this paper
• Domain exchangeability between the multidrug transporter (MDR1) and phosphatidylcholine flippase (MDR2).

  1999cites this paper
• Ligand-mediated Tertiary Structure Changes of Reconstituted P-glycoprotein

  1999cites this paper
• The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.

  1999cites this paper
• Membrane orientation of carboxyl-terminal half P-glycoprotein: topogenesis of transmembrane segments.

  1999cites this paper
• Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.

  1999cites this paper
• Dissection of de novo membrane insertion activities of internal transmembrane segments of ATP-binding-cassette transporters: toward understanding topological rules for membrane assembly of polytopic membrane proteins.

  1998cites this paper
• Dissection of drug-binding-induced conformational changes in P-glycoprotein.

  1998cites this paper